Loading search results
INTREP-AF
Sponsor study identifier
observational
120
1 country
1
Study Start
March 1, 2020
Actual (reported)Primary Completion
March 30, 2024
Actual (reported)Study Completion
December 1, 2024
Actual (reported)Friedreich's ataxia (FA) is the most frequent recessive genetic ataxia with an estimated prevalence of 1/50 000. The first symptoms appear around the age of 10 years with a progressive course and the need for an armchair 10- 15 years after the first symptoms. More rarely the disease can present with a late onset (after the age of 25) with a picture characterized by spastic paraparesis and slower progression ("LOFA" for "Late Onset Friedreich Ataxia" or VLOFA for "Very Late Appearance of Friedreich's ataxia "). AF is caused in 96% of cases by an expansion of GAAN triplets (N\> 100 repeats) located in intron 1 of the FXN gene, present on the two alleles, and, in the rest of the cases, by an associated expansion a point mutation or a deletion in trans. During molecular diagnostics, it is not uncommon to find the presence of interruptions within the GAA expansion. This results in the absence and / or the shift of peak (s) within the chromatogram. To date, only the partial correlation between the size of the expansion and the age of onset of Friedreich's ataxia has been established. In particular, very atypical forms of AF with a late onset (after the age of 25) are in particular explained by the low number of repetitions in the expansion, typically between 100 and 500 repetitions. However, the presence of an interruption could stabilize the size of the expansion and, therefore, be mainly associated with expansions of small sizes and therefore with a late onset of the disease. The objective of this study is therefore to analyse and caracterize the presence and the type of interruptions of the GAA expansions in a group of patients with FA ; this data will be correlated with the age at onset of FA.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2020
Actual (reported)April 10, 2020
Actual (reported)April 15, 2020
Actual (reported)March 30, 2024
Actual (reported)December 1, 2024
Actual (reported)Interruptions and date at onset
Study the correlation between the presence and type of interruptions (location within the expansion, nucleotide sequence: "GAAA", "GAG", etc.) and the age of onset of Friedreich's ataxia.
18 months
Clinical correlation
18 months
Patients with Friedriech Ataxia genetically confirmed
Reuse of existing data from patients' medical records
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with Friedriech Ataxia genetically confirmed. .
Uh Montpellier
Montpellier, Montpellier, 34295, France
Benkirane M, Marelli C, Choumert A, Goizet C, Patat O, Ewenczyk C, Anheim M, Megarbane A, Larrieu L, Charlin C, Ory-Magne F, Chaussenot A, Fradin M, Guissart C, Pointaux M, Cossee M, Vincent MC, Bergougnoux A, Hersent C, Bareil C, Roubertie A, Fluchere F, Renaud M, Kremer L, Tranchant C, Attarian S, Odent S, Laugel V, Walther-Louvier U, Desnous B, Bieth E, Husson I, Azulay JP; INTREP-AF consortium; Rivier F, Doray B, Durr A, Aouinti S, Molinari N, Koenig M. Type and position of repeat interruptions as determinants of disease severity and expansion size in Friedreich ataxia. Genet Med. 2025 Dec;27(12):101588. doi: 10.1016/j.gim.2025.101588. Epub 2025 Sep 23.
NC
Cecilia Marelli, MD
University Hospitals of Montpellier
120 participants (actual enrollment reported by the registry).
First Submitted
April 10, 2020
First Posted
April 15, 2020
Study Start
March 1, 2020
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
March 30, 2024
Actual (reported)Study Completion
December 1, 2024
Actual (reported)Last Updated
June 2, 2026
Record last verified: 2026-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: